Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial

Published:2017-12 Issue:1 Volume:18 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Gonzalez-Martinez Carmen, ,Kranzer Katharina,McHugh Grace,Corbett Elizabeth L.,Mujuru Hilda,Nicol Mark P.,Rowland-Jones Sarah,Rehman Andrea M.,Gutteberg Tore J.,Flaegstad Trond,Odland Jon O.,Ferrand Rashida A.

Funder

Medical Research Council Norway

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-017-2344-2.pdf

Reference31 articles.

1. Weber HC, Gie RP, Cotton MF. The challenge of chronic lung disease in HIV-infected children and adolescents. J Int AIDS Soc. 2013;16:18633. doi 10.7448/IAS.16.1.18633 .

2. Rylance J, Meghji J, Miller RF, Ferrand RA. Global considerations in human immunodeficiency virus-associated respiratory disease. Semin Respir Crit Care Med. 2016;37(2):166–80. doi: 10.1055/s-0036-1572555 .

3. Desai SR, Copley SJ, Barker RD, et al. Chest radiography patterns in 75 adolescents with vertically-acquired human immunodeficiency virus (HIV) infection. Clin Radiol. 2011;66(3):257–63. doi: 10.1016/j.crad.2010.10.009 .